Fernando Cabré Casas

Group CFO at Sinclair Pharma

Fernando Cabré Casas has a strong background in finance and business development. Fernando currently holds the position of Group CFO at Sinclair EBD. Prior to this, they worked at a family business as an Investment Manager and at Taurus Group as a Business Development Director. Fernando also has extensive experience at CNA Group, where they served as Group CFO and Business Unit Director. Fernando began their career at Dunnes Stores, initially as a Business Accountant and later as a Food Business Financial Analyst.

Fernando Cabré Casas has a diverse education history spanning multiple fields and disciplines. In 1995 to 1998, they attended Universitat Rovira i Virgili and completed a Degree in Business Administration, with a focus on Accounting and Finance. Following this, from 1998 to 2000, Fernando obtained a Bachelor of Business Administration (BBA) from the same institution, with a specialization in Strategy, Tax, and International Finance.

In 2003, they pursued further education and enrolled in the UCD Michael Smurfit Graduate Business School. There, they completed an Executive MBA program, focusing on International Finance. In the same year, Fernando also obtained a certification, becoming an Economist from Col.legi d´Economistes de Catalunya.

Continuing their education, from 2018 to 2019, Fernando attended the IESE Business School and completed the Advance Management Program (AMP), specializing in Strategic Management and Leadership. In 2019 to 2020, they further expanded their knowledge by participating in the DIBEX, Digital Business Executive Program at ISDI, where they focused on Digital Business.

In 2021, they pursued a Master of Trading Stock Market from BLACKBIRD BANK, with a specialization in Investments. Additionally, in 2010, Fernando obtained the Open Water Diver certification from PADI, further diversifying their skillset outside of their academic pursuits.

Links

Previous companies

Dunnes Stores logo

Timeline

  • Group CFO

    September, 2021 - present

View in org chart